Literature DB >> 55589

Cerebral thrombosis, cerebral haemorrhage, and ABO blood-groups.

D A Ionescu, I Marcu, E Bicescu.   

Abstract

The ABO blood-group distributions of 1460 patients who had died from a stroke were compared with those of a control group of 20 705 controls selected at random from the healthy population at risk (i.e., over thirty-five years of age and matched for age and sex ratio). The cause of death was certified as cerebral thrombosis in 329 cases and as cerebral haemorrhage in 482 cases, these diagnoses being established in neurological hospitals; the remaining 649 cases had an unspecified type of stroke, the diagnosis being made by general practitioners. In the group with unspecified type of stroke the blood-group distribution was practically the same as the distribution in the controls. In the thrombosis cases there was an excess of blood-groups A and AB and a deficiency of O and B; in cerebral haemorrhage this situation was reversed. However, these were only trends; the differences were not significant at the 5% level. A statistically significant difference did emerge when the A+AB excess in thrombosis was contrasted with the O+B excess in haemorrhage, suggesting that this difference might be accounted for the major A subgroup (A1) and, consequently, A1B.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 55589     DOI: 10.1016/s0140-6736(76)91405-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  7 in total

1.  O blood type is a risk factor for upper gastrointestinal bleeding.

Authors:  Massimo Franchini; Thomas Togliani; Rosalia Turdo; Giuseppe Lucchini; Carlo Bonfanti; Ivano Giacomini; Mario Luppi; Stefano Pilati
Journal:  J Thromb Thrombolysis       Date:  2018-01       Impact factor: 2.300

2.  Venous thromboembolism and ABO blood groups in a Brazilian population.

Authors:  W M Robinson; I Roisenberg
Journal:  Hum Genet       Date:  1980       Impact factor: 4.132

3.  ABO genotype and risk of thrombotic events and hemorrhagic stroke.

Authors:  K L Wiggins; N L Smith; N L Glazer; F R Rosendaal; S R Heckbert; B M Psaty; K M Rice; T Lumley
Journal:  J Thromb Haemost       Date:  2008-11-25       Impact factor: 5.824

4.  Erythrocyte rheology in acute cerebral thrombosis. Effects of ABO blood groups.

Authors:  D A Ionescu; M Ghitescu; I Marcu; A Xenakis
Journal:  Blut       Date:  1979-11

5.  Cardiovascular disease and ABO blood-groups in Africans. Are blood-group A individuals at higher risk of ischemic disease?: A pilot study.

Authors:  Djibril Marie Ba; Mamadou Saidou Sow; Aminata Diack; Khadidiatou Dia; Mouhamed Cherif Mboup; Pape Diadie Fall; Moussa Daouda Fall
Journal:  Egypt Heart J       Date:  2017-04-01

6.  Evaluation of blood type as a potential risk factor for early postpartum hemorrhage.

Authors:  Mais Ali-Saleh; Ofer Lavie; Yoram Abramov
Journal:  PLoS One       Date:  2019-04-04       Impact factor: 3.240

7.  Ischemic stroke is associated with the ABO locus: the EuroCLOT study.

Authors:  Frances M K Williams; Angela M Carter; Pirro G Hysi; Gabriela Surdulescu; Dylan Hodgkiss; Nicole Soranzo; Matthew Traylor; Steve Bevan; Martin Dichgans; Peter M W Rothwell; Cathie Sudlow; Martin Farrall; Kaisa Silander; Mari Kaunisto; Peter Wagner; Olli Saarela; Kari Kuulasmaa; Jarmo Virtamo; Veikko Salomaa; Philippe Amouyel; Dominique Arveiler; Jean Ferrieres; Per-Gunnar Wiklund; M Arfan Ikram; Albert Hofman; Giorgio B Boncoraglio; Eugenio A Parati; Anna Helgadottir; Solveig Gretarsdottir; Unnur Thorsteinsdottir; Gudmar Thorleifsson; Kari Stefansson; Sudha Seshadri; Anita DeStefano; Andreas Gschwendtner; Bruce Psaty; Will Longstreth; Braxton D Mitchell; Yu-Ching Cheng; Robert Clarke; Marco Ferrario; Joshua C Bis; Christopher Levi; John Attia; Elizabeth G Holliday; Rodney J Scott; Myriam Fornage; Pankaj Sharma; Karen L Furie; Jonathan Rosand; Mike Nalls; James Meschia; Thomas H Mosely; Alun Evans; Aarno Palotie; Hugh S Markus; Peter J Grant; Tim D Spector
Journal:  Ann Neurol       Date:  2013-01       Impact factor: 10.422

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.